Roivant Sciences Ltd. (ROIV)

Roivant Sciences Revenue

In the fiscal year ending March 31, 2025, Roivant Sciences had annual revenue of $29.05M, down -11.19%. Roivant Sciences had revenue of $7.57M in the quarter ending March 31, 2025, a decrease of -16.08%.

• Revenue (ttm): $29.05M
• Revenue Growth: -11.19%
• P/S Ratio: 283.64
• Revenue / Employee: $38,737
• Employees: 750
• Market Cap: 7.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	29.05M	-3.66M	-11.19%
Mar 31, 2024	32.71M	1.18M	3.75%
Mar 31, 2023	31.53M	-23.76M	-42.97%
Mar 31, 2022	55.29M	31.49M	132.34%
Mar 31, 2021	23.80M	-43.89M	-64.85%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.